Mill Valley, CA, United States of America

Wolfgang Michael Korn

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Wolfgang Michael Korn

Introduction

Wolfgang Michael Korn is a notable inventor based in Mill Valley, CA (US). He has made significant contributions to the field of precision medicine, particularly in the area of cancer treatment. With a total of 3 patents, his work focuses on utilizing comprehensive molecular profiling to enhance treatment efficacy for cancer patients.

Latest Patents

One of his latest patents is titled "Classifying an entity for FOLFOX treatment." This innovation involves comprehensive molecular profiling that provides valuable data regarding the molecular status of patient samples. By comparing this data to patient responses to treatments, Korn aims to identify biomarker signatures that can predict responses to FOLFOX, a treatment combining 5-fluorouracil/leucovorin with oxaliplatin. The patent describes data structures, data processing, and machine learning models designed to predict the effectiveness of treatments based on specific biomarkers.

Another significant patent is the "Pan-cancer platinum response predictor." This invention also leverages comprehensive molecular profiling to identify biomarker signatures that correlate with cancer patients' responses to platinum-based chemotherapy. The patent outlines methods for selecting treatments based on molecular profiles, thereby enhancing the precision of cancer therapies.

Career Highlights

Wolfgang Michael Korn is currently associated with Caris Mpi, Inc., where he continues to innovate in the field of molecular profiling and cancer treatment. His work has the potential to transform how treatments are selected for patients, leading to more personalized and effective care.

Collaborations

Korn collaborates with notable colleagues such as Jim Abraham and David Spetzler, contributing to a dynamic team focused on advancing cancer treatment methodologies.

Conclusion

Wolfgang Michael Korn's contributions to the field of precision medicine through his innovative patents highlight the importance of molecular profiling in cancer treatment. His work not only enhances our understanding of patient responses but also paves the way for more effective therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…